Antibiotics and the burn patient

Area of Science:

• Infectious Diseases
• Burn Care
• Pharmacology

Background:

• Hospital-acquired infections pose significant challenges in burn care, particularly those caused by multi-resistant Gram-negative bacteria.
• Limited development of new antibiotics necessitates careful management of existing antimicrobial agents.

Purpose of the Study:

• To develop evidence-based guidelines for antibiotic use in burn patients.
• To optimize antibiotic strategies to combat multi-resistant bacterial infections in burn wounds.

Main Methods:

• Expert review by the French Society of Burn Injuries (SFETB).
• Analysis of key antibiotic management principles: appropriate use, timing, bactericidal activity, combination therapy, de-escalation, and duration.
• Consideration of pharmacokinetic and pharmacodynamic (PK/PD) properties of antibiotics.
• Inclusion of antibioprophylaxis, infection diagnosis, bacterial inoculation, and local treatment strategies.

Main Results:

• Established criteria for appropriate antibiotic use in burn patients.
• Defined optimal timing, duration, and regimens based on PK/PD principles.
• Addressed critical aspects of infection diagnosis and local wound management.

Conclusions:

• Judicious use of current antibiotics is crucial due to the lack of new drug development.
• Implementation of these guidelines aims to improve outcomes in burn patients with multi-resistant infections.
• French guidelines for antibiotic use in burn patients have been developed.